Login / Signup

Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial.

Derick T WadeJames CooperNicholas PeckhamMaurizio Belci
Published in: Clinical rehabilitation (2020)
It is feasible to undertake a larger trial. We recommend broader inclusion criteria to increase eligibility and generalizability.
Keyphrases
  • urinary tract infection
  • study protocol
  • spinal cord injury
  • double blind
  • clinical trial
  • randomized controlled trial
  • open label
  • phase iii
  • placebo controlled
  • phase ii
  • oxidative stress